Skip to main content
Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.040
-0.020 (-1.89%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Lucid Diagnostics Revenue

In the year 2025, Lucid Diagnostics had annual revenue of $4.71M with 8.28% growth. Lucid Diagnostics had revenue of $1.50M in the quarter ending December 31, 2025, with 25.65% growth.

Revenue (ttm)
$4.71M
Revenue Growth
+8.28%
P/S Ratio
41.69
Revenue / Employee
$57,390
Employees
82
Market Cap
196.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.71M360.00K8.28%
Dec 31, 20244.35M1.92M79.00%
Dec 31, 20232.43M2.05M544.03%
Dec 31, 2022377.00K-123.00K-24.60%
Dec 31, 2021500.00K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 348.67M
InfuSystem Holdings 143.44M
Sight Sciences 77.36M
Electromed 68.86M
CVRx, Inc. 56.65M
908 Devices 56.20M
Apyx Medical 52.84M
TriSalus Life Sciences 45.15M
Revenue Rankings

LUCD News

More News